An open label, interventional, multi-center, prospective clinical study to evaluate efficacy and safety of â??IMPERIMÂ® Capsulesâ?? in patients suffering from mild to moderate erectile dysfunction - NI

Dr Bioveda Lab0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects who have scored 13 to 24 on the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) at screening.
•2.Subject without any organic cause of Erectile Dysfunction.
•3.Subjects should be in an active stable sexual relationship for the duration of study
•4.Subject willing to participate in clinical trial and who have read, understood and signed informed consent form
•5.Subjects willing to make all required study visits
•6.Subjects willing to follow study instructions given by the investigator

•1.Subjects with major illnesses and sexual dysfunction due to anatomical surgical or pharmacological causes
•2.History of radical prostatectomy or other pelvic surgery or penile implant, or a clinically significant penile deformity
•3.Presence of any drug or therapy that may have relation with ED and sexual dysfunction
•4.Subjects with total erectile failure or any other sexual disorder, hypogonadism or anatomical deformity of the penis such as severe penile fibrosis or Peyronie disease or penile trauma
•5. Subjects with preexisting systemic disease necessitating long-term medications
•6.Continuing history of alcohol and or drug abuse
•7.Subjects with significant abnormal laboratory parameters

发起方

Dr Bioveda Lab